07 June 2023: Database Analysis
Database Analysis
Bin Zhu 1AE* , MingNan Cao 1BF* , Qiao Wu 2BC , Kejia Liu 3BC , Wei Guo 4AD* , Zhigang Zhao 1AD*DOI: 10.12659/MSM.939546
Med Sci Monit 2023; 29:e939546
Table 4 Association between low-dose aspirin intake and hyperuricemia based on race and eGFR, respectively. Confounding factors were adjusted by logistic regression analysis in different models.
| Models | Race* | eGFR (mL/min/m2)a | |||||
|---|---|---|---|---|---|---|---|
| Hispanic American | Non-Hispanic American | Black | Other | ≥90 | 60–89 | <60 | |
| 1.52 (1.11–2.08) | 1.67 (1.15–2.43) | 2.05 (1.20–3.51) | 1.48 (1.05–2.10) | 1.16 (0.87–1.55) | |||
| 1.08 (0.75–1.56) | 1.16 (0.76–1.75) | 1.31 (0.67–2.58) | 1.34 (0.90–1.99) | 0.95 (0.68–1.33) | |||
| 1.05 (0.70–1.57) | 1.14 (0.74–1.77) | 1.42 (0.70–2.90) | 1.40 (0.94–2.09) | 1.00 (0.71–1.41) | |||
| * Data are presented as odds ratio (95% CI). Significant associations are marked in bold. crude model; : for race, we adjusted for age, sex, body mass index, smoking, excessive alcohol consumption, physical activity, hypertension, and diabetes; for estimated glomerular filtration rate, we adjusted for age, sex, body mass index, race, smoking, excessive alcohol consumption, physical activity, hypertension, and diabetes; for race, we adjusted for factors in Model 2, plus estimated glomerular filtration rate, total cholesterol, triglycerides, high-density lipoprotein, and low-dose lipoprotein; for eGFR, we adjusted for factors in Model 2, plus total cholesterol, triglycerides, high-density lipoprotein, and low-dose lipoprotein. | |||||||